Ma W, Hu Z B, Drexler H G
DSM, German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig.
Leukemia. 1994 Feb;8(2):336-42.
We examined the sensitivity of different myeloperoxidase (MPO) detection methods in leukemia cell lines. To this end the MPO-positive acute promyelocytic leukemia cell line NB-4 was diluted into cell populations of the MPO-negative myeloma cell line MM-1 at different ratios. MPO protein was identified by classical cytochemical staining and by a specific anti-MPO monoclonal antibody in an immunofluorescent reaction. Cytochemical staining detected 1% positive cells among 99% negative cells. Careful, but time-consuming observation enabled the detection of positive cells in even higher dilutions. At least a 10-fold increase in sensitivity was achieved with the immunofluorescent method, as brightly fluorescent cells are more amenable for a screening of slides at lower microscopic magnification than the cytochemically visualized cells. MPO mRNA expression was examined in whole cell populations by Northern blotting (maximal sensitivity 1%), a reverse transcriptase-polymerase chain reaction (RT-PCR) amplification assay (sensitivity 0.1%), and by RT-PCR followed by Southern blotting (sensitivity 0.05%). The high sensitivity of PCR-based techniques is offset by the fact that these methods do not allow for the identification and further characterization of the individual, MPO-positive cells. Thus, methods examining bulk populations require homogeneous cell samples in order to avoid false-positivity stemming from a few residual bystander cells. The five different techniques were used to determine the status of MPO expression in 20 randomly chosen leukemia cell lines of myelomonocytic origin. In 11 cell lines (8 positive and 3 negative) all five tests provided concordant results. Three cell lines were Northern-negative, but RT-PCR-positive and MPO protein-positive suggesting that Northern blot analysis is the least sensitive tool. Six cell lines were devoid of MPO protein, at least according to the methods used here, but trace expression of MPO message was documented by PCR. All five techniques have advantages and drawbacks and must be carefully selected in order to obtain useful data. The detection of MPO is of experimental and clinical importance in the distinction of myeloid from lymphoid leukemias, and in the lineage assignment of apparently biphenotypic or unclassifiable cases.
我们检测了不同髓过氧化物酶(MPO)检测方法在白血病细胞系中的敏感性。为此,将MPO阳性的急性早幼粒细胞白血病细胞系NB-4以不同比例稀释到MPO阴性的骨髓瘤细胞系MM-1的细胞群体中。通过经典细胞化学染色和免疫荧光反应中特异性抗MPO单克隆抗体鉴定MPO蛋白。细胞化学染色在99%的阴性细胞中检测到1%的阳性细胞。仔细但耗时的观察能够在更高稀释度下检测到阳性细胞。免疫荧光法的敏感性至少提高了10倍,因为与细胞化学可视化的细胞相比,荧光明亮的细胞更便于在较低显微镜放大倍数下筛选玻片。通过Northern印迹法(最大敏感性1%)、逆转录聚合酶链反应(RT-PCR)扩增试验(敏感性0.1%)以及RT-PCR后进行Southern印迹法(敏感性0.05%)检测全细胞群体中的MPO mRNA表达。基于PCR的技术具有高敏感性,但这些方法无法对单个MPO阳性细胞进行鉴定和进一步表征。因此,检测大量细胞群体的方法需要均匀的细胞样本,以避免因少数残留的旁观者细胞导致假阳性。使用这五种不同技术来确定20个随机选择的髓单核细胞来源的白血病细胞系中MPO的表达状态。在11个细胞系中(8个阳性和3个阴性),所有五项检测结果一致。三个细胞系Northern印迹法检测为阴性,但RT-PCR检测为阳性且MPO蛋白阳性,这表明Northern印迹分析是最不敏感的工具。六个细胞系没有MPO蛋白,至少根据这里使用的方法是这样,但PCR记录了MPO信息的微量表达。所有五种技术都有优缺点,必须仔细选择以获得有用的数据。MPO的检测在区分髓系白血病和淋巴系白血病以及在明确双表型或无法分类病例的谱系归属方面具有实验和临床重要性。